0001127602-14-027199.txt : 20140904
0001127602-14-027199.hdr.sgml : 20140904
20140904162428
ACCESSION NUMBER: 0001127602-14-027199
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140902
FILED AS OF DATE: 20140904
DATE AS OF CHANGE: 20140904
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARIAD PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000884731
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 223106987
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 26 LANDSDOWNE ST
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 6174940400
MAIL ADDRESS:
STREET 1: 26 LANDSDOWNE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FITZGERALD EDWARD M
CENTRAL INDEX KEY: 0001242993
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36172
FILM NUMBER: 141083481
MAIL ADDRESS:
STREET 1: C/O ARIAD PHARMACEUTICALS INC
STREET 2: 26 LANDSDOWNE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2014-09-02
0000884731
ARIAD PHARMACEUTICALS INC
ARIA
0001242993
FITZGERALD EDWARD M
C/O ARIAD PHARMACEUTICALS, INC.
26 LANDSDOWNE STREET
CAMBRIDGE
MA
02139
1
Executive VP, CFO
Common Stock
2014-09-02
4
M
0
25000
5.23
A
305960
D
Common Stock
2014-09-02
4
S
0
25000
6.2167
D
280960
D
Common Stock
2014-09-02
4
M
0
25000
5.23
A
305960
D
Common Stock
2014-09-02
4
S
0
25000
6.2167
D
280960
D
Employee Stock Option (Right to Buy)
5.23
2014-09-02
4
M
0
25000
0
D
2006-09-09
2014-09-09
Common Stock
25000
25000
D
Employee Stock Option (Right to Buy)
5.23
2014-09-02
4
M
0
25000
0
D
2006-09-09
2014-09-09
Common Stock
25000
0
D
Shares were acquired upon the exercise of outstanding stock options at $5.23 per share.
This sale was pursuant to a 10b5-1 trading plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.14 to $6.34, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Security and Exchange Commission, upon request, full information regarding the shares sold at each separate price within the range set forth in this footnote.
/s/Edward M. Fitzgerald
2014-09-04